Sign in
GNTA Stock Price, Chart, Stats & News
Genenta Science S.p.A.
Save
36.76M
Market cap
–
Current P/E
–
Forward P/E
GNTA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -40.37% |
ROE | -70.71% |
D/E | 0.62x |
Interest coverage ratio | -12.84x |
GNTA valuation
P/E | – |
P/S | – |
P/B | 0.95x |
P/CF | -1.85x |
P/FCF | -1.88x |
P/OCF | -1.85x |
PEG | -0.38x |
EV multiple | -1.09x |
About
Genenta Science S.p. A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation.
Similar securities
Based on sector and market capitalization
Report issue